Patients with High Restenosis Risk Benefit More from Drug Eluting Stents

AudioMedica News
AudioMedica News
Patients with High Restenosis Risk Benefit More from Drug Eluting Stents
Loading
/
Raul Moreno
Raul Moreno

REFERENCE: Abstract 3103, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
RAUL MORENO, University Hospital La Paz, Madrid
Results from a large meta analysis suggest that drug eluting stents have a greater benefit when the risk of restenosis increases. This could affect the “off label” use of these stents. Raul Moreno, of the University Hospital La Paz, Madrid, discussed his findings with Derek Thorne.

[audio:https://www.audiomedica.com/podcasting/cardio/070904_raul_moreno.mp3]

Further reading